Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
June 01, 2025 10:00 ET | Source: Replimune Group Inc - RP1…
From Declaration to Action: Advancing Global Graft Fight under IAACA Steer
HONG KONG, May 31, 2025 /PRNewswire/ -- In May last year, the…
Singapore Unveils Insights from World’s First Technical Testing of Real World Applications of GenAI
First Global AI Assurance Pilot brought global testing companies and GenAI deployers…
Rays Power Infra Ltd Achieves Record Revenue of 1350 Crore in FY25, Up 29% from Previous Year
NEW DELHI, May 30, 2025 /PRNewswire/ -- Rays Power Infra Limited, a…
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS)…
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
May 28, 2025 19:43 ET | Source: Nxera Pharma Tokyo, Japan and…
Club de Madrid: Imperial Springs International Forum (ISIF) amplifies global call for cooperation and dialogue from Madrid
MADRID, May 28, 2025 /PRNewswire/ -- In a context of rising geopolitical uncertainty,…
1000 teams from Professional Colleges Across India Vie for Top Honours at UST SIGHT 2.0 Competition
Winners presented with cash prizes, certificates and mementos THIRUVANANTHAPURAM, India, May 28,…
Gastops Receives Investment from RTX for Next Generation Monitoring Technologies
Investment made possible by Canadian Industrial and Technological Benefits Policy (ITB) OTTAWA,…
From Triumph to Tomorrow: Bakery China 2025 Wraps Up, Prepares for Next Chapter
SHANGHAI, May 27, 2025 /PRNewswire/ -- Bakery China 2025 concluded its record-setting…